PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 2, 2025Journal of Clinical Medicine3 citationsOpen Access

Adherence to Guideline-Directed Medical Therapy in Hospitalized Older People with Heart Failure at Discharge and 3-Month Follow-Up

View Full Paper
RRRenee C. M. A. RaijmannMHMargje H. HaverkampMMManon G. van der Meer

Key Points

  • Adherence to guideline-directed medical therapy is notably low among older patients with heart failure.
  • At discharge, only 15% of patients received the four recommended GDMT drugs, improving to 26% after three months.
  • A retrospective cohort study analyzed factors influencing adherence in hospitalized patients aged 70 and older.
  • Common reasons for non-adherence included adverse effects and individual patient circumstances like life expectancy.

Abstract

Objectives: Heart failure is one of the leading causes of hospitalization in older adults. Guideline-directed medical therapy (GDMT) reduces the risk of decompensation and hospitalization, though it is challenging to implement GDMT in this group. Therefore, this study evaluated adherence to the 2021 ESC heart failure guideline in older patients and explored reasons for guideline deviations. Methods: A retrospective cohort study was performed in older patients (70+ years) with decompensated heart failure (ejection fraction 80 years) received GDMT less frequently at discharge compared to younger patients (4% vs. 26%, p = 0.03). Though this difference was resolved at follow-up. The other studied factors were not significantly associated with GDMT adherence. Common reasons for guideline deviations were adverse effects, contraindications, reduced life expectancy, and postponed treatment. Conclusions: Adherence to GDMT in older heart failure patients is low due to several reasons, such as relevant contraindications. Physicians should carefully balance the risks and benefits of the guideline versus individual benefit, considering life expectancy and individual care goals.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Raijmann et al. (2025) studied this question.

synapsesocial.com/papers/68de79685b556a9128e1a95dhttps://doi.org/10.3390/jcm14196928
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 12021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2021 · 13,613 citations
  2. 2An Observational Study of Evidence-Based Therapies in Older Patients with Heart Failure with Reduced Ejection Fraction: Insights from a Dedicated Heart Failure Clinic2024 · 7 citations
  3. 3Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction2023 · 19 citations
  4. 4Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults2017 · 284 citations
  5. 5Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial2022 · 1,089 citations